| |
| |
|
| Insider
Information: |
Pitzer Kenneth R |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
380,123 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,466,722 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
380,123 |
|
|
| Total
Value |
$3,466,722 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Theravance Biopharma, Inc. |
TBPH |
|
2022-02-18 |
380,123 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
SVP, PROD STRAT & COMM PLNG |
• – – |
2022-02-18 |
4 |
D |
$9.61 |
$262,343 |
D/D |
(27,299) |
380,123 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, PROD STRAT & COMM PLNG |
• – – |
2022-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
52,000 |
407,422 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2021-08-20 |
4 |
D |
$14.05 |
$60,513 |
D/D |
(4,307) |
359,732 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2021-05-20 |
4 |
D |
$17.80 |
$76,718 |
D/D |
(4,310) |
364,039 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2021-02-20 |
4 |
D |
$18.79 |
$599,983 |
D/D |
(31,931) |
368,349 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
400,280 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2020-11-20 |
4 |
D |
$17.21 |
$82,728 |
D/D |
(4,807) |
335,280 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2020-08-20 |
4 |
D |
$18.22 |
$87,529 |
D/D |
(4,804) |
340,087 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2020-05-20 |
4 |
D |
$26.67 |
$128,203 |
D/D |
(4,807) |
344,891 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$754,622 |
D/D |
(29,136) |
349,698 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
378,834 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2019-11-20 |
4 |
D |
$17.60 |
$39,987 |
D/D |
(2,272) |
259,834 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2019-08-20 |
4 |
D |
$21.51 |
$48,871 |
D/D |
(2,272) |
262,106 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2019-05-20 |
4 |
D |
$19.84 |
$45,076 |
D/D |
(2,272) |
264,378 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2019-02-20 |
4 |
D |
$27.00 |
$99,198 |
D/D |
(3,674) |
266,650 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
270,324 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2018-11-20 |
4 |
D |
$24.79 |
$96,879 |
D/D |
(3,908) |
158,074 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2018-08-20 |
4 |
D |
$26.95 |
$135,909 |
D/D |
(5,043) |
161,982 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2018-05-20 |
4 |
D |
$24.31 |
$456,517 |
D/D |
(18,779) |
167,025 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
185,804 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2018-02-20 |
4 |
D |
$29.09 |
$123,691 |
D/D |
(4,252) |
152,054 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
156,306 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2017-11-20 |
4 |
D |
$28.58 |
$143,300 |
D/D |
(5,014) |
147,306 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2017-08-20 |
4 |
D |
$27.40 |
$137,356 |
D/D |
(5,013) |
152,320 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Prod Strat & Comm Plng |
• – – |
2017-05-20 |
4 |
D |
$36.83 |
$184,666 |
D/D |
(5,014) |
157,333 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
